XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.2
Earnings Per Share
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table sets forth the calculation of basic and diluted earnings per share:

 BasicDiluted
 Second Quarter
 2024202320242023
($ in millions, except per share amounts,
shares in millions)
Net income$737 $356 $737 $356 
Dividend equivalent payments(1)— (1)— 
Income available to common stockholders$736 $356 $736 $356 
Weighted-average shares outstanding226.0 227.5 226.0 227.5 
Dilutive effect of outstanding options and share-settled awards  0.4 0.5 
Adjusted weighted-average shares outstanding  226.4 228.0 
Earnings per share$3.26 $1.56 $3.25 $1.56 
 BasicDiluted
 First Six Months
 2024202320242023
($ in millions, except per share amounts,
shares in millions)
Net income$790 $822 $790 $822 
Dividend equivalent payments(2)(1)(2)(1)
Income available to common stockholders$788 $821 $788 $821 
Weighted-average shares outstanding225.9 227.6 225.9 227.6 
Dilutive effect of outstanding options and share-settled awards  0.4 0.5 
Adjusted weighted-average shares outstanding 226.3 228.1 
Earnings per share$3.49 $3.61 $3.48 $3.60 
During the second quarters and first six months of 2024 and 2023, dividend equivalent payments were made to certain holders of stock options and RSUs.  For purposes of computing basic earnings per share, dividend equivalent payments made to holders of stock options and RSUs were deducted from net income to determine income available to common stockholders. For purposes of computing diluted earnings per share, we evaluate on a grant-by-grant basis those stock options and RSUs receiving dividend equivalent payments under the two-class and treasury stock methods to determine which method is more dilutive for each grant. For those grants for which the two-class method was more dilutive, net income was reduced by dividend equivalent payments to determine income available to common stockholders. The dilution calculations exclude options having exercise prices exceeding the average market price of Common Stock as follows: 0.1 million in the second quarters and first six months ended June 30, 2024 and 2023.